Pfizer Inc. and BioNTech SE announced today that the FDA has approved their COVID-19 vaccine for adults ages 65 and older and individuals from 5 to 64 years old who have at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. The approval comes amidst the development of a… The post Pfizer and BioNTech’s COVID vaccine approved for individuals at increased risk appeared first on Drug Discovery and Development.| Drug Discovery and Development
The U.S. Centers for Disease Control and Prevention chose Retsef Levi, a management and health analytics expert at MIT, to lead its COVID-19 immunization workgroup. Levi announced on X that he is “looking forward to working with colleagues… to pursue the truth through science and evidence-based approach.” Levi, one of the eight new ACIP members… The post ACIP’s COVID vaccine workgroup to be headed by vaccine skeptic Retsef Levi appeared first on Drug Discovery and Development.| Drug Discovery and Development